Wonbiogen Co Ltd
KOSDAQ:307280
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Z
|
ZAZZ Energy of Sweden AB (publ)
STO:ZAZZ B
|
SE |
|
Avantor Inc
NYSE:AVTR
|
US |
Wonbiogen Co Ltd
Retained Earnings
Wonbiogen Co Ltd
Retained Earnings Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Retained Earnings | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
W
|
Wonbiogen Co Ltd
KOSDAQ:307280
|
Retained Earnings
₩31.4B
|
CAGR 3-Years
17%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
I
|
I Sens Inc
KOSDAQ:099190
|
Retained Earnings
₩193.8B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
2%
|
CAGR 10-Years
9%
|
|
|
C
|
Classys Inc
KOSDAQ:214150
|
Retained Earnings
₩547.5B
|
CAGR 3-Years
39%
|
CAGR 5-Years
42%
|
CAGR 10-Years
147%
|
|
|
W
|
Won Tech Co Ltd
KOSDAQ:336570
|
Retained Earnings
₩74.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
V
|
Viol Co Ltd
KOSDAQ:335890
|
Retained Earnings
₩75.4B
|
CAGR 3-Years
88%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
S
|
Seers Technology Co Ltd
KOSDAQ:458870
|
Retained Earnings
-₩45.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Wonbiogen Co Ltd
Glance View
Wonbiogen Co., Ltd. engages in the research and development of biocompatible medical materials. The company is headquartered in Gumi, Gyeongsangbuk-Do. The company went IPO on 2018-12-05. The firm provides medical products including dressing material used for lower leg ulcers, pressure ulcers and surgical wounds; dressing material for secretions absorption and wound area protection; fixing band for bandages, gauze, catheters, along with others.
See Also
What is Wonbiogen Co Ltd's Retained Earnings?
Retained Earnings
31.4B
KRW
Based on the financial report for Sep 30, 2025, Wonbiogen Co Ltd's Retained Earnings amounts to 31.4B KRW.
What is Wonbiogen Co Ltd's Retained Earnings growth rate?
Retained Earnings CAGR 3Y
17%
Over the last year, the Retained Earnings growth was 10%. The average annual Retained Earnings growth rates for Wonbiogen Co Ltd have been 17% over the past three years .
